| [1] |
Cui P, Jin Y, Feng HZ, Li ZT, Ding SN, Li YZ. Burden of carbon monoxide poisoning in China, 1990-2019: a systematic analysis of data from the global burden of disease study 2019. Front Public Health. 2022; 10: 930784.
doi: 10.3389/fpubh.2022.930784
|
| [2] |
Rose JJ, Wang L, Xu QZ, McTiernan CF, Shiva S, Tejero J, et al. Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy. Am J Respir Crit Care Med. 2017; 195(5): 596-606.
doi: 10.1164/rccm.201606-1275CI
|
| [3] |
Savioli G, Gri N, Ceresa IF, Piccioni A, Zanza C, Longhitano Y, et al. Carbon monoxide poisoning: from occupational health to emergency medicine. J Clin Med. 2024; 13(9): 2466.
doi: 10.3390/jcm13092466
|
| [4] |
Thom SR, Bhopale VM, Milovanova TM, Hardy KR, Logue CJ, Lambert DS, et al. Plasma biomarkers in carbon monoxide poisoning. Clin Toxicol (Phila). 2010; 48(1): 47-56.
doi: 10.3109/15563650903468209
pmid: 20095814
|
| [5] |
Rückerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, et al. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 2006; 173(4): 432-41.
doi: 10.1164/rccm.200507-1123OC
|
| [6] |
Simonsen C, Magnusdottir SO, Andreasen JJ, Wimmer R, Rasmussen BS, Kjaergaard B, et al. Metabolic changes during carbon monoxide poisoning: an experimental study. J Cell Mol Med. 2021; 25(11): 5191-201.
doi: 10.1111/jcmm.16522
pmid: 33949122
|
| [7] |
Penney DG, Helfman CC, Hull JA, Dunbar JC, Verma K. Elevated blood glucose is associated with poor outcome in the carbon-monoxide-poisoned rat. Toxicol Lett. 1990; 54(2-3): 287-98.
|
| [8] |
Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman ÅK, Kalnapenkis A, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023; 24(9): 1540-51.
doi: 10.1038/s41590-023-01588-w
pmid: 37563310
|
| [9] |
Chen YH, Lu TY, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023; 55(1): 44-53.
doi: 10.1038/s41588-022-01270-1
pmid: 36635386
|
| [10] |
Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011; 40(3): 740-52.
doi: 10.1093/ije/dyq151
pmid: 20813862
|
| [11] |
Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016; 32(20): 3207-9.
|
| [12] |
Lin ZT, Deng YQ, Pan W. Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet. 2021; 17(11): e1009922.
doi: 10.1371/journal.pgen.1009922
|
| [13] |
Cohen JF, Chalumeau M, Cohen R, Korevaar DA, Khoshnood B, Bossuyt PMM. Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol. 2015; 68(3): 299-306.
doi: 10.1016/j.jclinepi.2014.09.005
|
| [14] |
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol. 2015; 44(2): 512-25.
doi: 10.1093/ije/dyv080
pmid: 26050253
|
| [15] |
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5): 377-89.
doi: 10.1007/s10654-017-0255-x
pmid: 28527048
|
| [16] |
Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021; 36(5): 465-78.
doi: 10.1007/s10654-021-00757-1
pmid: 33961203
|
| [17] |
Martínez VG, Moestrup SK, Holmskov U, Mollenhauer J, Lozano F. The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev. 2011; 63(4): 967-1000.
doi: 10.1124/pr.111.004523
pmid: 21880988
|
| [18] |
Brossard C, Semichon M, Trautmann A, Bismuth G. CD 5 inhibits signaling at the immunological synapse without impairing its formation. J Immunol. 2003; 170(9): 4623-9.
doi: 10.4049/jimmunol.170.9.4623
pmid: 12707340
|
| [19] |
Vandenberghe P, Ceuppens JL. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5. Eur J Immunol. 1991; 21(2): 251-9.
pmid: 1705509
|
| [20] |
Matson CA, Choi S, Livak F, Zhao B, Mitra A, Love PE, et al. CD 5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation. Proc Natl Acad Sci USA. 2020; 117(25): 14342-53.
doi: 10.1073/pnas.1922525117
|
| [21] |
Wang R, Li KJ, Wang Z, Wang YY, Zhang HF. Changes of nuclear factor kappa-B pathway activity in hippocampus after acute carbon monoxide poisoning and its role in nerve cell injury. Mol Neurobiol. 2024; 61(8): 5206-15.
doi: 10.1007/s12035-023-03889-5
pmid: 38172287
|
| [22] |
Ruhela D, Bhopale VM, Kalakonda S, Thom SR. Astrocyte-derived microparticles initiate a neuroinflammatory cycle due to carbon monoxide poisoning. Brain Behav Immun Health. 2021; 18: 100398.
|
| [23] |
De Wolde SD, Hulskes RH, Weenink RP, Hollmann MW, Van Hulst RA. The effects of hyperbaric oxygenation on oxidative stress, inflammation and angiogenesis. Biomolecules. 2021; 11(8): 1210.
doi: 10.3390/biom11081210
|
| [24] |
He MY, Roussak K, Ma FY, Borcherding N, Garin V, White M, et al. CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses. Science. 2023; 379(6633): eabg2752.
|
| [25] |
Kim JA, Jang JH, Lee SY. An updated comprehensive review on vitamin A and carotenoids in breast cancer: mechanisms, genetics, assessment, current evidence, and future clinical implications. Nutrients. 2021; 13(9): 3162.
doi: 10.3390/nu13093162
|
| [26] |
Bonelli R, Woods SM, Lockwood S, Bishop PN, Khan KN, Bahlo M, et al. Spatial distribution of metabolites in the retina and its relevance to studies of metabolic retinal disorders. Metabolomics. 2023; 19(2): 10.
doi: 10.1007/s11306-022-01969-6
pmid: 36745234
|
| [27] |
Li X, Yao X, Wen JY, Chen QL, Zhu ZM, Zhang XY, et al. The application of sphingomyelin in mediating the causal role of the T-cell surface glycoprotein CD5 in Crohn’s disease: a two-step Mendelian randomization study. Medicine (Baltimore). 2024; 103(46): e40513.
doi: 10.1097/MD.0000000000040513
|
Open Access 
)
